Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ophthalmic drug development: procedural considerations

¹PharmaLogic Development, Inc., San Rafael, CA 94903, USA.

Journal of Glaucoma

|June 17, 1998

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ophthalmic drug delivery: development and regulatory considerations.

Clinical pharmacology and therapeutics·2009

Same author

Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization.

Journal of glaucoma·2001

Same author

Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjects.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2001

Same author

Submission of data sets to journals: what's the real issue?

Archives of ophthalmology (Chicago, Ill. : 1960)·2000

Same author

Update on regulatory review intervals for ophthalmic new drug applications at the United States Food and Drug Administration.

American journal of ophthalmology·2000

Same author

Financing new drug development in ophthalmology.

Journal of glaucoma·2000